The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Leukemia. 2024 Feb;38(2):442-445.
doi: 10.1038/s41375-024-02157-2.
Epub 2024 Jan 23.
1 Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany. Kathrin.Nachtkamp@med.uni-duesseldorf.de.
2 Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.
3 Department of Hematology and Medical Oncology, Georg August University, Göttingen, Germany.
4 Institute of Human Genetics, Heinrich Heine University, Düsseldorf, Germany.
5 Department of Hematology, Oncology and Palliative Care, Marien Hospital, Duesseldorf, Germany.
6 Department of Hematology, Oncology and Clinical Immunology, Johannes Hospital, Duisburg, Germany.
7 Centre Hospitalier Universitaire Vaudois, Service d'hématologie, Département d'oncologie, and Lausanne University (UNIL), Lausanne, Switzerland.
8 Department of Hematology and Oncology, University Hospital, Mannheim, Germany.
9 Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.
10 Ludwig Boltzmann Institute for Hematology and Oncology, Hanusch Hospital and Medical University of Vienna, Vienna, Austria.
11 Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
12 Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
13 Institute of Pathology, Heinrich Heine University, Düsseldorf, Germany.
14 Department of Internal Medicine, Medical University, Innsbruck, Austria.
15 Elisabethinen Hospital, Linz, Austria.
16 Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.